The Global PET MRI Systems Market, valued at USD 138.7 Million in 2025, is projected to exhibit a CAGR of 9.5%, reaching USD 261.8 Million by 2032.
Market growth is primarily driven by the rising demand for advanced hybrid imaging technologies that combine functional and anatomical imaging for enhanced diagnostic accuracy. Increasing applications of PET-MRI in oncology, neurology, and cardiology, along with the growing prevalence of cancer and neurological disorders, are fueling adoption worldwide.
Moreover, continuous technological advancements—such as AI-enabled image reconstruction, improved detector technologies, and reduced radiation exposure—are expanding the clinical utility of these systems. Supportive regulatory frameworks, rising healthcare investments, and the integration of PET-MRI in research and precision medicine are expected to further propel the market expansion over the forecast period.
Market Takeaways
Global PET MRI Systems Market Report Coverage
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/pet-mri-systems-market
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 138.7 Million |
|
Estimated Value by 2032 |
USD 261.8 Million |
|
Growth Rate |
Poised to exhibit a CAGR of 9.5% |
|
Historical Data |
2020-2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD Million) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Trends |
|
|
Opportunities |
|
|
Restraints & Challenges |
|
Market Dynamics
The global PET MRI systems market is witnessing robust growth, driven by increasing demand for advanced hybrid imaging technologies that combine the anatomical precision of MRI with the metabolic insights of PET. The growing prevalence of cancer, neurological, and cardiovascular diseases has accelerated the adoption of PET-MRI systems in both clinical and research settings. Continuous advancements in imaging software, detector technology, and workflow automation are further enhancing diagnostic accuracy and efficiency, supporting greater clinical utilization.
Technological innovations are playing a pivotal role in reshaping the market landscape. Developments such as helium-free PET-MRI systems, AI-powered image reconstruction, and quantitative imaging analytics are improving image quality, reducing operational costs, and streamlining diagnostic processes. Preclinical PET-MRI systems are witnessing particularly high demand from research institutions and pharmaceutical companies for drug discovery, biomarker validation, and translational research. Meanwhile, clinical systems are expanding their presence in hospitals for oncology, neurology, and cardiology applications.
However, high system costs, limited availability of trained operators, and the need for advanced infrastructure remain key challenges restricting wider adoption, particularly in developing regions. Despite these constraints, the market outlook remains positive, supported by increasing R&D investments, strategic collaborations among imaging technology providers, and expanding applications in personalized medicine and molecular diagnostics. These factors are expected to drive sustainable market growth through 2032.
Market Trends
Artificial intelligence (AI) and machine learning are increasingly integrated into PET-MRI systems to enhance image reconstruction speed, improve lesion detection, and automate workflow processes. These technologies help reduce scan times, minimize artifacts, and deliver higher diagnostic accuracy. AI-driven tools also assist clinicians in quantitative analysis and protocol standardization, improving efficiency and enabling broader adoption of PET-MRI in both clinical and research settings.
In December 2024, Siemens Healthineers unveiled its recent PET/MR scanner BIOGRAPH One at RSNA 2024, which incorporates AI-powered image reconstruction and streamlined workflow features (e.g., Deep Resolve, large axial FOV PET detector, simplified patient-slot time).
PET-MRI systems are gaining traction beyond oncology, expanding into neurology, pediatric imaging, and soft-tissue assessment due to their superior anatomical and functional imaging capabilities. In neurology, PET-MRI enables precise mapping of brain metabolism and connectivity, supporting early diagnosis of Alzheimer’s and Parkinson’s disease. In pediatrics, reduced radiation exposure makes PET-MRI safer for children. Additionally, its high soft-tissue contrast is driving adoption in musculoskeletal and cardiovascular imaging applications.
At the May ISMRM 2024 conference, an abstract titled “Hybrid Positron Emission Tomography and MRI (PET-MRI) with [18F]FDG for identifying musculoskeletal pain generators: Early experience” described how PET/MRI is being applied in musculoskeletal/soft-tissue imaging (chronic back pain, hip pain) for identifying pain generators.
Market Opportunities
With healthcare increasingly shifting toward decentralized care settings, there is an opportunity for mobile or portable PET-MRI systems designed for ambulatory care centres, mobile imaging vans, and community hospitals. These systems allow providers to bring advanced hybrid imaging closer to patients, reduce travel burden, and increase scan throughput in underserved regions.
As healthcare providers face rising energy costs and regulatory pressure on greenhouse gas emissions, system vendors can differentiate through PET-MRI platforms that use helium-free magnet technology, lower power consumption, and carbon-efficient designs. Such “green” scanners align with institutional ESG goals and may unlock faster procurement cycles in regions prioritizing sustainability.
In May 2023, Philips introduced its BlueSeal Magnet for MR operations, marking a major sustainability milestone as the industry’s first 1.5 T fully sealed magnet. The system requires only 0.5% of the helium used in conventional MRI scanners, significantly reducing helium dependency, maintenance needs, and infrastructure costs while supporting environmentally sustainable imaging operations.
Analyst View
Key Development
Competitive Landscape
PET MRI Systems Market Segmentation
Regional Insights
Related Reports :